Abstract:Obstructive sleep apnea (OSA) is a sleep breathing disorder characterized by recurrent episodes of complete or partial collapse of the upper airway during sleep, leading to airflow obstruction and associated with decreased oxygen saturation or arousal from sleep. In OSA patients, nocturnal intermittent hypoxemia causes excessive activation of hypoxia-inducing factor pathway, eventually increasing hemoglobin levels. OSA patients with hyperhemoglobinemia may have higher risk of cardiovascular, cerebrovascular, and metabolic diseases. Continuous positive airway pressure maintains a stable positive airway pressure to effectively prevent airway obstruction during sleep and is a primary treatment for OSA, reducing hypoxia and delaying the progression of various complications. However, its clinical compliance remains poor. In recent years, interest in pharmacological interventions has become a research focus. This article reviews the latest research progress in OSA with hyperhemoglobinemia, providing a theoretical basis for future studies.